Pharma is clearly not done fighting drug-pricing reforms

As is well-known, pharma companies’ recent campaign against drug-pricing reforms didn’t end well for the industry.

Their attack on the Democrats’ bill fell short over the summer, culminating in provisions that are being rolled out now as part of the Inflation Reduction Act.